PharmaFocus: Biomarkers in Alzheimer’s Disease...市場調査レポートについてご紹介

【英文タイトル】PharmaFocus: Biomarkers in Alzheimer’s Disease

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 11
1.2 List of Figures 14
2 Introduction 15
2.1 Catalyst 15
3 Alzheimer’s Disease Overview 16
3.1 Continuum of AD – Preclinical, MCI and AD Dementia 16
3.1.1 Preclinical AD 17
3.1.2 MCI 18
3.1.3 AD Dementia 19
3.2 Etiology and Pathophysiology 19
3.2.1 Etiology 19
3.2.2 Pathophysiology 22
4 AD Biomarkers – Overview 34
4.1 What are Biomarkers? 34
4.2 Criteria for Good Biomarkers 35
4.2.1 Sensitivity and Specificity of Biomarkers 36
4.3 Role of Biomarkers in AD Diagnosis 37
4.3.1 Challenges in Establishing AD Biomarkers as Diagnostic Tools 38
4.4 Role of Biomarkers in Drug Development 38
4.5 Biomarker Development and Validation 41
4.6 Classes of AD Biomarkers by Pathophysiological Mechanism 42
4.6.1 Temporal Evolution of Biomarkers 44
5 Unmet Needs Assessment 47
5.1 Overview 47
5.2 Unmet Needs Analysis 48
5.2.1 Patient and Physician Knowledge/Awareness of AD Diagnosis 48
5.2.2 Generalized Biomarker Unmet Needs 51
5.2.3 Unmet Need for Diverse Types of Biomarkers 54
6 AD Biomarkers Market Drivers and Barriers 59
6.1 Driver: Increasing prevalence of AD corresponding to a growth in the aging population will rapidly expand the biomarker market size 59
6.2 Driver: Anticipated future cost of biologic AD treatments will drive the use of biomarker diagnostics 60
6.3 Driver: Favorable regulatory standards for the application of biomarkers in drug discovery 61
6.4 Barrier: Present lack of disease-modifying treatments hinders the use of diagnostic tests 61
6.5 Barrier: Rigorous, expensive, and time-consuming nature of biomarker development and validation 62
6.6 Barrier: Reimbursement restrictions for diagnostic testing 63
6.7 Barrier: Healthcare system and physician practice barriers limit patient referral to specialists and the use of biomarker tests 63
7 Amyloid Beta Biomarkers 66
7.1 Overview of Biomarker Class 66
7.2 Drug Therapies Targeting Amyloid Beta 67
7.2.1 Overview 67
7.2.2 Representative Pipeline Drugs 67
7.3 Amyloid Biomarker Assays 69
7.3.1 Amyloid PET-Imaging 69
7.3.2 CSF-Based Amyloid Assays 80
7.3.3 Other Amyloid Assays in Development 87
8 Tau-Related Biomarkers 90
8.1 Overview of Biomarker Class 90
8.2 Drug Therapies Targeting Tau 90
8.2.1 Overview 90
8.2.2 Representative Products 90
8.3 Tau Biomarker Assays 92
8.3.1 CSF-Based Tau Assays 93
8.3.2 Promising Pipeline Products – Tau PET Imaging Ligands 98
9 Beyond Amyloid and Tau: Other Molecular AD Biomarkers in Development 100
9.1 Overview 100
9.1.1 Neuronal and Synaptic Degeneration 100
9.1.2 Inflammation and Oxidative Stress 101
9.2 Promising Pipeline Products 104
9.2.1 Alzheimer’s CSF 16-Plex Assay (Proteome Sciences) 104
9.3 Blood-Based Biomarkers 105
9.3.1 Overview 105
9.3.2 Promising Pipeline Products 107
10 Functional Brain Imaging Biomarkers 114
10.1 Overview of Biomarker Class 114
10.2 Functional Brain Imaging Assays 114
10.2.1 FDG-PET 115
10.2.2 FMRI Biomarkers of AD 118
11 Structural Brain Imaging Biomarkers 123
11.1 Overview of Biomarker Class 123
11.2 Structural Brain Imaging Assays 124
11.2.1 MRI Hippocampal Volumetry 125
11.2.2 Other Structural Imaging Biomarkers in Pipeline Development 128
12 Regulatory Considerations Impacting AD Biomarkers 130
12.1 Clinical Trial Design in AD Drug Development 130
12.1.1 Regulatory Agency Recommendations 133
12.1.2 Key Opinion Leaders on the Use of Biomarkers in Drug Clinical Trials 134
12.1.3 Mapping the Use of Biomarkers in Key AD Drug Clinical Trials 139
12.1.4 AD Drug Approval, Population or Stage-Specific Indications, and Off-Label Use 140
12.2 Reimbursement of Biomarker-Based Testing 141
12.2.1 Concerns Limiting Reimbursement of Biomarker Testing for AD 141
12.2.2 Region-Specific Differences in Biomarker Test Reimbursement Policies and Pathways in the US and EU 145
13 Outlook and Opportunities for AD Biomarkers 148
13.1 Overview 148
13.2 Key Players, Partnerships, and Associations 150
13.2.1 National and International AD Biomarkers Consortia 151
13.2.2 Private Industry Biomarker Partnerships 152
13.3 Opportunity Analysis 153
13.3.1 Opportunity: Biomarkers to Determine Appropriate Use of Treatment 154
13.3.2 Opportunity: Biomarkers as Populations Screens for Alzheimer’s Disease 155
13.3.3 Opportunity: Continued Development of Varied Biomarkers of Pathophysiology 155
14 Appendix 156
14.1 Bibliography 156
14.2 Abbreviations 170
14.3 Research Methodology 174
14.4 Physicians and Specialists Included in this Study 175
14.5 About the Authors 176
14.5.1 Authors 176
14.5.2 Global Head of Healthcare 177
14.6 About GlobalData 178
14.7 Disclaimer 178


【レポート販売概要】

■ タイトル:PharmaFocus: Biomarkers in Alzheimer’s Disease
■ 英文:PharmaFocus: Biomarkers in Alzheimer’s Disease
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161287
■ 調査対象地域:グローバル
  • 線量測定器の世界市場
    ABSTRACTAbout Dosimetry Equipment Dosimetry equipment is used to measure the amount of energy deposited by ionizing radiation. The devices are used to measure and estimate the effective dose received by the human body through exposure to external ionizing radiation. Dosimetry equipment devices are used in places where people deal with hazardous waste or radioactive substances such as hospitals and …
  • フランスの手術室用装置市場見通し(~2021)
    France Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "France Operating Room Equipment Market Outlook to 2021", provides key market data on the France Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables, Operating Room Lights …
  • クラウド課金ソリューションの世界市場
    In the midst of intense competition, companies are striving for recurring businesses from existing customers. This helps them in anticipating revenue based on continuous transactions and in establishing more lucrative supplier–customer relationships. The subscription-based business models are revolutionizing the traditional businesses and are creating new opportunities for organizations. These org …
  • 主変圧器(車載)の世界市場予測(~2022年)
    “Traction transformer market to exhibit moderate growth potential between 2016 and 2022”The traction transformer market is expected to grow at a CAGR of 4.6% between 2016 and 2022 and is likely to be valued at USD 724.2 million by 2022. The key driving factors for the growth of the traction transformer market are the significant government funding for railway infrastructure development, liberaliza …
  • ハイヒールシューズの世界市場2019-2023
    About this market The demand for premium footwear is expected to rise rapidly owing to high disposable income and celebrity endorsements for various footwear brands. Advances in footwear manufacturing and innovative product designs also increase sales of premium footwear. These famous brands along with many regional players also manufacture customized high heel footwear for better customer satisfa …
  • Comprehensive Messaging Package
    The Comprehensive Messaging Package is a comprehensive package that includes many reports in the areas of messaging (SMS, MMS, IM, etc.), next generation messaging, SMS Aggregators, and related areas (see Table of Contents for full list). The package includes technology and market analysis, ecosystem and value chain analysis, and will help the reader understand next generation networks and the fut …
  • 医療におけるRFIDの世界市場分析:製品別(システム、タグ)、セグメント予測
    RFID in the healthcare market is expected to witness significant growth and reach over USD 3.89 billion over the next seven years owing to major factors such as growing utilization in patient & product tracking. Technological advancements including the development of new products namely TexTrace RFID tag and Smart Face Technology are expected to fuel demand. Furthermore, improving efficiency of in …
  • パン改良剤の世界市場予測(~2022年):乳化剤、酵素、酸化剤、還元剤
    “The bread improvers market is projected to grow at a CAGR of 5.2%”The bread improvers market is projected to reach USD 4.08 billion by 2022 at a CAGR of 5.2% from 2017 to 2022. The market is driven by factors such as the increasing consumption of bread and its related products, innovation in bakery products, demand for organic bread improvers, and increase in demand for convenience foods. “Emulsi …
  • 永久磁石の世界市場分析:材料別(アルミニウムニッケルコバルト(AlNiCo)、フェライト、サマリウムコバルト(SaCo)、ネオジム鉄ホウ素(NdFeB))、用途別(自動車、電子、産業、エネルギー、航空宇宙、医療)、セグメント予測
    The permanent magnet market is expected to reach USD 30.44 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to exhibit significant growth owing to increasing use of high performance products as radar arrays, fluid flow meters, door actuators and braking systems in aircraft. In addition, growing adoption of the product in space applications coupled with …
  • 濾過および汚染制御の世界市場予測(~2022)
    The global filtration and contamination control market is expected to reach USD 39.73 Billion by 2022, at a CAGR of 5.13% between 2017 and 2022. The market is expected to grow substantially owing to the growing demand for cleaner fuels due to stringent environmental emission standards, strong demand for filtration across on-road and off-road applications; and requirement of higher power efficiency …
  • 世界の産業用ボイラー市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Industrial Boiler market to grow at a CAGR of 2.82 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand of industrial boilers from developing countries. The Global Industrial Boiler market has also been witnessing the increasing focus toward R&D activities. However, the need for high investmen …
  • 中国の注射器・注射針市場見通し(~2021)
    China Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "China Syringes and Needles Market Outlook to 2021", provides key market data on the China Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syringes. The report also p …
  • BG Group plc:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013
    BG Group plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary BG Group plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operation …
  • ヘルプデスク業務アウトソーシングの世界市場
    About Helpdesk Outsourcing Helpdesk outsourcing refers to the process of engaging an external resource or service provider to provide technical support to employees and manage the same. It has gained in popularity over the past few years as firms are seeking to minimize in-house expenses. Apart from the inherent cost advantages, it can aid in enhancing the productivity within a short time because …
  • 業務用スープジャーの世界市場2017-2021
    ABSTRACTAbout Commercial Soup Warmer The global commercial countertop soup warmer market was valued at $289.64 million in 2016, owing to the increase in demand for countertop models with improved features and innovative technologies. For instance, Roband Australia provides countertop soup warmers with cauldron-shaped design and glass-filled nylon outer casing so that the heat transfer is reduced a …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。